127 related articles for article (PubMed ID: 6174137)
1. Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
Raghavan D; Peckham MJ; Heyderman E; Tobias JS; Austin DE
Br J Cancer; 1982 Feb; 45(2):167-73. PubMed ID: 6174137
[TBL] [Abstract][Full Text] [Related]
2. Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
Peckham MJ; Barrett A; McElwain TJ; Hendry WF; Raghavan D
Br J Urol; 1981 Apr; 53(2):162-72. PubMed ID: 6165424
[TBL] [Abstract][Full Text] [Related]
3. Tumour-marker levels and prognosis in malignant teratoma of the testis.
Germa-Lluch JR; Begent RH; Bagshawe KD
Br J Cancer; 1980 Dec; 42(6):850-5. PubMed ID: 6161630
[TBL] [Abstract][Full Text] [Related]
4. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours.
Peckham MJ; Barrett A; Husband JE; Hendry WF
Lancet; 1982 Sep; 2(8300):678-80. PubMed ID: 6126625
[TBL] [Abstract][Full Text] [Related]
5. Testicular tumour markers in tissue correlated to serum levels and clinical stage.
Alm P; Hultberg B; Olsson AM
Scand J Urol Nephrol; 1984; 18(4):283-8. PubMed ID: 6209794
[TBL] [Abstract][Full Text] [Related]
6. Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis.
Sogani PC; Whitmore WF; Herr HW; Bosl GJ; Golbey RB; Watson RC; DeCosse JJ
J Clin Oncol; 1984 Apr; 2(4):267-70. PubMed ID: 6200576
[TBL] [Abstract][Full Text] [Related]
7. Single institutional experience with non-seminomatous germ cell tumours of the testis: local perspectives on a curable cancer.
Rosenthal MA; Stuart-Harris RC; Tiver KW; Langlands AO; Kefford RF
Aust N Z J Med; 1991 Dec; 21(6):857-62. PubMed ID: 1726358
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
9. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
11. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
Uysal Z; Bakkaloğlu M
Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
[TBL] [Abstract][Full Text] [Related]
12. Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
Seckl MJ; Rustin GJ; Bagshawe KD
Br J Cancer; 1990 Jun; 61(6):916-8. PubMed ID: 1695522
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis, prevalence, prognosis and treatment of the trophoblastic component in germinal tumours of the testis in the adult].
Ewald N; Roth A; Nezelof C; Cukier J
J Urol (Paris); 1982; 88(6):325-35. PubMed ID: 6294186
[TBL] [Abstract][Full Text] [Related]
14. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
15. Germ cell tumours of testis: prognostic factors and results.
Nikzas D; Champion AE; Fox M
Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
[TBL] [Abstract][Full Text] [Related]
16. The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling time--I. Theoretical basis and practical application.
Price P; Hogan SJ; Horwich A
Eur J Cancer; 1990 Apr; 26(4):450-3. PubMed ID: 1694086
[TBL] [Abstract][Full Text] [Related]
17. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
[TBL] [Abstract][Full Text] [Related]
18. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
[TBL] [Abstract][Full Text] [Related]
19. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
20. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
Horwich A; Peckham MJ
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1463-70. PubMed ID: 6209145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
